The iMODERN trial (“iFR Guided Multi-vessel Revascularization During Percutaneous Coronary Intervention for Acute Myocardial Infarction.”) trial is an ongoing multinational study. This study will provide important knowledge on the best practice for the assessment and treatment of multi-vessel disease involving ST-segment elevation myocardial infarction (STEMI) patients.
We spoke with Professor Robin Nijveldt, Cardiologist at Radboud University Medical Center in Nijmegen, the Netherlands about this ongoing prospective, randomized controlled, multicentre study.
Learn more at https://bit.ly/3dQR0wM
For more cardiology research news, join Cardiology Update on Facebook, Twitter, LinkedIn or Instagram.
Keywords: cardiology, cardiologist, heart, medicine, doctor, cardiology-update
